MTNB vs ROL · rev $1.1M vs P/E 41, rev $3.39B
Matinas BioPharma Holdings Inc (MTNB) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
Matinas BioPharma Holdings Inc (MTNB) is a biotechnology company listed on US.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Latest reported MTNB revenue for 2023-12-31 was $1.1M. Net income was -$22.9M. Revenue was down 65.6% from 2022-12-31 to 2023-12-31. MTNB currently screens at market cap $5.6M.
Latest reported ROL revenue for 2024-12-31 was $3.39B. Net income was $466.4M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
MTNB currently screens at market cap $5.6M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the MTNB and ROL stock pages for the full models.
Not investment advice.